Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient
- Conditions
- Type 2 diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT20170112031893N3
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
type 2 diabetes over three year
age group40-75
Distal polyneuropathy resolutions based on questionnaires Michigan
HBA1C8% -10%
Kidney,liver,and heart failure based on the tests, history and physical exam
High blood pressure more than 180 mm Hg and advanced ;
diabetic Retinopathy
Pergnancy and lactation
History of amputation
Fever
the recent use of drugs for neuropathy {gabapentin , nortriptyline}
?Consumers of medicines that induce delayed gastric emptying such as: Acarbose, Miglitol, Exenatid, ?benzodiazepines, calcium channel blockers, narcotics, alpha-2 adrenergic receptor agonists such as ?clonidine, tricyclic antidepressants, dopamine agonists, cholinergic muscarinic receptor antagonists, ?Octreotide, phenothiazines, cyclosporine
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood sugar. Timepoint: pre and early post-treatment. Method of measurement: Based on Labratory.
- Secondary Outcome Measures
Name Time Method Distal polyneuropathy. Timepoint: Before and 3 months after the intervention. Method of measurement: Michigan Questionnaire A.